298
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

HPLC method for determination of moxifloxacin in plasma and its application in pharmacokinetic analysis

, &

References

  • Kanellakopoulou, K.; Galanopoulos, I.; Soranoglou, V.; Tsaganos, T.; Tziortzioti, V.; Maris, I.; Papalois, A.; Giamarellou, H.; Giamarellos-Bourboulis, E. J. Treatment of Experimental Osteomyelitis Caused by Methicillin-resistant Staphylococcus aureus with a Synthetic Carrier of Calcium Sulphate (Stimulan®) Releasing Moxifloxacin. Int. J. Antimicrob. Agents 2009, 33, 354–359.
  • Balfour, J. A.; Lamb, H. M. Moxifloxacin: A Review of its Clinical Potential in the Management of Community-acquired Respiratory Tract Infections. Drugs 2000, 59, 115–139.
  • Zhang, L.; Li, L.; Shi, W.; Liu, S.; Liang, X.; Ye, Z.; Wang, W. J.; Zhang, B.; Li, R.; Chen, Y.; Yu, C.; Zhuo, L.; Wang, X. Pharmacokinetics of Moxifloxacin in Critically ill Patients with Impaired Renal Function Undergoing Pulse High-volume Haemofiltration. Int. J. Antimicrob. Agents 2013, 42, 244–249.
  • Keating, G. M.; Scott, L. J. Moxifloxacin: A Review of its Use in the Management of Bacterial Infections. Drugs 2004, 64, 2347–2377.
  • Gupta, U. D.; Vemuri, N.; Gupta, P.; Kumar, V.; Tanushree, P.; Khuller, G. K. Efficacy of Moxifloxacin and Econazole Against Multidrug Resistant (MDR) Mycobacterium tuberculosis in Murine Model. Indian J. Med. Res. 2015, 142, 323–329.
  • Burman, W. J.; Goldberg, S.; Johnson, J. L.; Muzanye, G.; Engle, M.; Mosher, A. W.; Choudhri, S.; Daley, C. L.; Munsiff, S. S.; Zhao, Z.; Vernon, A.; Chaisson, R. E. Moxifloxacin Versus Ethambutol in the First 2 Months of Treatment for Pulmonary Tuberculosis. Am. J. Respir. Crit. Care Med. 2006, 174, 331–338.
  • Conde, M. B.; Efron, A.; Loredo, C.; De Souza, G. R.; Graca, N. P.; Cezar, M. C.; Ram, M.; Chaudhary, M. A.; Bishai, W. R.; Kritski, A. L.; Chaisson, R. E. Moxifloxacin Versus Ethambutol in the Initial Treatment of Tuberculosis: A Double-blind, Randomised, Controlled Phase II Trial. Lancet 2009, 373, 1183–1189.
  • Razzaq, S. N.; Ashfaq, M.; Khan, I. U.; Mariam, I.; Razzaq, S. S.; Azeem, W. Simultaneous Determination of Dexamethasone and Moxifloxacin in Pharmaceutical Formulations using Stability Indicating HPLC Method. Arabian J. Chem. 2014 in press. doi:10.1016/j.arabjc.2014.11.016.
  • Lim, J. H.; Lee, D. H.; Lee, S. T.; Kim, N.; Park, Y. S.; Shin, C. M.; Song, I. S. Moxifloxacin-containing Triple Therapy After Non-bismuth Quadruple Therapy Failure for Helicobacter pylori Infection. World J. Gastroenterol. 2015, 21, 13124–13131.
  • Kalariya, P. D.; Namdev, D.; Srinivas, R.; Gananadhamu, S. Application of Experimental Design and Response Surface Technique for Selecting the Optimum RP-HPLC Conditions for the Determination of Moxifloxacin HCl and Ketorolac Tromethamine in Eye Drops. J. Saudi Chem. Soc. 2014 in press. doi:10.1016/j.jscs.2014.04.004.
  • Kumar, A. K. H.; Sudha, V.; Srinivasan, R.; Ramachandran, G. Simple and Rapid Liquid Chromatography Method for Determination of Moxifloxacin in Saliva. J. Chromatogr. B 2011, 879, 3663–3667.
  • Djurdjevic, P.; Ciric, A.; Djurdjevic, A.; Stankov, M. J. Optimization of Separation and Determination of Moxifloxacin and its Related Substances by RP-HPLC. J. Pharm. Biomed. Anal. 2009, 50, 117–126.
  • Xu, Y. H.; Li, D.; Liu, X. Y.; Li, Y. Z.; Lu, J. High Performance Liquid Chromatography Assay with Ultraviolet Detection for Moxifloxacin: Validation and Application to a Pharmacokinetic Study in Chinese Volunteers. J. Chromatogr. B 2010, 878, 3437–3441.
  • Chan, K. P.; Chu, K. O.; Lai, W. W. K.; Choy, K. W.; Wang, C. C.; Lam, D. S. C.; Pang, C. P. Determination of Ofloxacin and Moxifloxacin and their Penetration in Human Aqueous and Vitreous Humor by using High-performance Liquid Chromatography Fluorescence Detection. Anal. Biochem. 2006, 353, 30–36.
  • Laban-Djurdjević, A.; Jelikić-Stankov, M.; Djurdjević, P. Optimization and Validation of the Direct HPLC Method for the Determination of Moxifloxacin in Plasma. J. Chromatogr. B 2006, 844, 104–111.
  • Cavazos-Rocha, N.; Carmona-Alvarado, I.; Vera-Cabrera, L.; Waksman-de-Torres, N.; Salazar-Cavazos, L. HPLC Method for the Simultaneous Analysis of Fluoroquinolones and Oxazolidinones in Plasma. J. Chromatogr. Sci. 2014, 52, 1281–1287.
  • Wang, L.; Xu, Y.; Liang, L.; Diao, C.; Liu, X.; Zhang, J.; Zhang, S. LC–MS/MS Method for the Simultaneous Determination of PA-824, Moxifloxacin and Pyrazinamide in Rat Plasma and its Application to Pharmacokinetic Study. J. Pharm. Biomed. Anal. 2014, 97, 1–8.
  • Vu, D. H.; Koster, R. A.; Alffenaar, J. W. C.; Brouwers, J. R. B. J.; Uges, D. R. A. Determination of Moxifloxacin in Dried Blood Spots using LC–MS/MS and the Impact of the Hematocrit and Blood Volume. J. Chromatogr. B 2011, 879, 1063–1070.
  • Vishwanathan, K.; Bartlett, M. G.; Stewart, J. T. Determination of Moxifloxacin in Human Plasma by Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2002, 30, 961–968.
  • Yang, Z.; Qin, W. Separation of Fluoroquinolones in Acidic Buffer by Capillary Electrophoresis with Contactless Conductivity Detection. J. Chromatogr. A 2009, 1216, 5327–5332.
  • Cruz, L. A.; Hall, R. Enantiomeric Purity Assay of Moxifloxacin Hydrochloride by Capillary Electrophoresis. J. Pharm. Biomed. Anal. 2005, 38, 8–13.
  • Culley, C. M.; Lacy, M. K.; Klutman, N.; Edwards, B. Moxifloxacin: Clinical Efficacy and Safety. Am. J. Health Syst. Pharm. 2001, 58, 379–388.
  • Kim, B. H.; Choi, N. H.; Ok, J. H. Comparison of Reversed-phase Liquid Chromatographic Methods for the Separation of the New Quinolones. J. Chromatogr. Sci. 2002, 40, 369–376
  • Czyrski, A Analytical Methods for Determining Third and Fourth Generation Fluoroquinolones: A Review. Chromatographia 2017, 80, 181–200.
  • Lemione, T.; Breilh, D.; Ducint, D.; Dubrez, J.; Jougon, J.; Velly, J. F.; Saux, M. C. Deterimination of Moxifloxacin (BAY-12–8039) in Plasmaand Lung Tissue by High-performance Liquid Chromatography with Ultraviolet Detection using a Fully Automated Extraction Method with a New Polymeric Catridge. J. Chromatogr. B 2000, 742, 247–254.
  • Helmy, S. A. Simultaneous Quantification of Linezolid, Tinidazole, Norfloxacin, Moxifloxacin, Levofloxacin, and Gatifloxacin in Human Plasma for Therapeutic Drug Monitoring and Pharmacokinetic Studies in Human Volunteers. Ther. Drug Monit. 2013, 35, 770–777.
  • EMA. Guideline on bioanalytical method validation. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf, entry (accessed September 1, 2016).
  • Liang, H.; Kays, M. B.; Sowinski, K. M. Separation of Levofloxacin, Ciprofloxacin, Gatifloxacin, Moxifloxacin, Trovafloxacin and Cinoxacin by High-performance Liquid Chromatography: Application to Levofloxacin Determination in Human Plasma. J. Chromatogr. B 2002, 772, 53–63.
  • Kontou, P.; Manika, K.; Chatzika, K.; Papaioannou, M.; Sionidou, M.; Pitsiou, G.; Kioumis, I. Pharmacokinetics of Moxifloxacin and High-dose Levofloxacin in Severe Lower Respiratory Tract Infections. Int. J. Antimicrob. Agents 2013, 42, 262–267.
  • Böttcher, S.; Baum, H.; Hoppe-Tichy, T.; Benz, C.; Sonntag, H. G. An HPLC Assay and a Microbiological Assay to Determine Levofloxacin in Soft Tissue, Bone, Bile and Serum. J. Pharm. Biomed. Anal. 2001, 25, 197–203.
  • Czyrski, A.; Kondys, K.; Szałek, E.; Karbownik, A.; Grześkowiak, E. The Pharmacokinetic Interaction Between Levofloxacin and Sunitinib. Pharmacol. Rep. 2015, 67, 542–544.
  • Forrest, A.; Ballow, C.; Nix, D.; Birmingham, M.; Schentag, J. Development of a Population Pharmacokinetic Model on Optimal Sampling Strategies for Intravenous Ciprofloxacin. Antimicrob. Agents Chemother. 1993, 37, 1065–1072.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.